| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Receptor Coactivator 3 | 34 | 2024 | 348 | 5.200 |
Why?
|
| Nuclear Receptor Coactivator 1 | 13 | 2021 | 241 | 2.030 |
Why?
|
| Trans-Activators | 15 | 2015 | 800 | 1.610 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 8 | 2012 | 376 | 1.400 |
Why?
|
| Nuclear Receptor Coactivators | 7 | 2024 | 72 | 1.320 |
Why?
|
| Antineoplastic Agents | 11 | 2024 | 1650 | 1.310 |
Why?
|
| Nuclear Receptor Coactivator 2 | 9 | 2023 | 203 | 1.140 |
Why?
|
| Proteasome Endopeptidase Complex | 15 | 2020 | 263 | 1.110 |
Why?
|
| Neoplasms | 8 | 2024 | 2764 | 1.000 |
Why?
|
| Receptors, Steroid | 6 | 2022 | 275 | 0.960 |
Why?
|
| Transcriptional Activation | 11 | 2024 | 484 | 0.950 |
Why?
|
| Transcription, Genetic | 16 | 2023 | 1696 | 0.910 |
Why?
|
| Cell Line, Tumor | 31 | 2024 | 3331 | 0.890 |
Why?
|
| Ubiquitin | 7 | 2009 | 141 | 0.890 |
Why?
|
| Transcription Factors | 11 | 2022 | 2582 | 0.850 |
Why?
|
| Repressor Proteins | 8 | 2021 | 816 | 0.830 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2024 | 883 | 0.780 |
Why?
|
| Bufanolides | 3 | 2015 | 17 | 0.710 |
Why?
|
| Receptors, Estrogen | 10 | 2019 | 797 | 0.700 |
Why?
|
| Signal Transduction | 15 | 2024 | 4504 | 0.690 |
Why?
|
| Breast Neoplasms | 11 | 2023 | 2498 | 0.690 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2021 | 1892 | 0.690 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2017 | 100 | 0.660 |
Why?
|
| Stress, Physiological | 2 | 2019 | 251 | 0.660 |
Why?
|
| Cell Proliferation | 13 | 2024 | 2286 | 0.660 |
Why?
|
| Gene Expression Regulation | 16 | 2023 | 2522 | 0.630 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2019 | 235 | 0.630 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 548 | 0.620 |
Why?
|
| B7-H1 Antigen | 1 | 2019 | 109 | 0.620 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 254 | 0.600 |
Why?
|
| Animals | 51 | 2024 | 34047 | 0.590 |
Why?
|
| MCF-7 Cells | 8 | 2021 | 222 | 0.520 |
Why?
|
| Molecular Targeted Therapy | 3 | 2017 | 353 | 0.520 |
Why?
|
| Genomics | 2 | 2022 | 1492 | 0.520 |
Why?
|
| Histone Acetyltransferases | 8 | 2008 | 314 | 0.510 |
Why?
|
| Drug Design | 1 | 2017 | 147 | 0.510 |
Why?
|
| Estrogen Receptor alpha | 11 | 2018 | 468 | 0.500 |
Why?
|
| Mice | 32 | 2024 | 17626 | 0.490 |
Why?
|
| Proteolysis | 3 | 2014 | 170 | 0.470 |
Why?
|
| Autoantigens | 5 | 2020 | 118 | 0.460 |
Why?
|
| Trichothecenes | 1 | 2014 | 4 | 0.460 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2024 | 716 | 0.450 |
Why?
|
| Nuclear Proteins | 8 | 2020 | 1265 | 0.440 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2014 | 99 | 0.430 |
Why?
|
| Humans | 72 | 2024 | 124257 | 0.400 |
Why?
|
| Selective Estrogen Receptor Modulators | 2 | 2004 | 60 | 0.400 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2024 | 218 | 0.400 |
Why?
|
| HeLa Cells | 15 | 2015 | 806 | 0.390 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2020 | 723 | 0.380 |
Why?
|
| Chromatin | 3 | 2018 | 552 | 0.370 |
Why?
|
| Tamoxifen | 3 | 2023 | 363 | 0.350 |
Why?
|
| Embryo Implantation | 2 | 2023 | 233 | 0.320 |
Why?
|
| Multifactorial Inheritance | 1 | 2009 | 138 | 0.310 |
Why?
|
| Neoplasm Proteins | 3 | 2019 | 668 | 0.300 |
Why?
|
| Chromosome Positioning | 1 | 2008 | 4 | 0.300 |
Why?
|
| Proteasome Inhibitors | 4 | 2021 | 61 | 0.300 |
Why?
|
| Disease | 1 | 2009 | 129 | 0.300 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2009 | 443 | 0.270 |
Why?
|
| Uterus | 2 | 2023 | 569 | 0.270 |
Why?
|
| Energy Metabolism | 5 | 2022 | 774 | 0.270 |
Why?
|
| Ligands | 5 | 2023 | 531 | 0.260 |
Why?
|
| Cell Movement | 5 | 2022 | 835 | 0.260 |
Why?
|
| Oxidative Stress | 3 | 2024 | 800 | 0.260 |
Why?
|
| Protein Binding | 10 | 2018 | 1738 | 0.260 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2023 | 214 | 0.250 |
Why?
|
| Metabolic Diseases | 1 | 2007 | 129 | 0.250 |
Why?
|
| Cell Nucleus | 3 | 2010 | 676 | 0.250 |
Why?
|
| Models, Genetic | 2 | 2007 | 759 | 0.240 |
Why?
|
| Stromal Cells | 3 | 2022 | 299 | 0.240 |
Why?
|
| Endometrium | 4 | 2023 | 281 | 0.240 |
Why?
|
| Homeostasis | 3 | 2020 | 685 | 0.240 |
Why?
|
| Estrogens | 5 | 2018 | 514 | 0.230 |
Why?
|
| Protein Processing, Post-Translational | 6 | 2016 | 356 | 0.230 |
Why?
|
| Female | 31 | 2024 | 66312 | 0.220 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2024 | 28 | 0.220 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2004 | 16 | 0.220 |
Why?
|
| Hydrogen Peroxide | 1 | 2024 | 112 | 0.220 |
Why?
|
| Adenine | 1 | 2024 | 102 | 0.220 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2023 | 294 | 0.220 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 113 | 0.210 |
Why?
|
| Th17 Cells | 1 | 2024 | 90 | 0.210 |
Why?
|
| Cyclohexanones | 2 | 2020 | 17 | 0.210 |
Why?
|
| Receptors, Androgen | 2 | 2024 | 413 | 0.200 |
Why?
|
| Mice, Knockout | 10 | 2023 | 3727 | 0.200 |
Why?
|
| Cell Survival | 7 | 2024 | 806 | 0.200 |
Why?
|
| Fibroblasts | 2 | 2024 | 882 | 0.200 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2022 | 38 | 0.200 |
Why?
|
| RNA | 2 | 2023 | 570 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 8 | 2023 | 1328 | 0.190 |
Why?
|
| Phosphorylation | 6 | 2020 | 1615 | 0.190 |
Why?
|
| Forkhead Transcription Factors | 2 | 2022 | 356 | 0.190 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2023 | 139 | 0.190 |
Why?
|
| Genes, Reporter | 3 | 2017 | 381 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 2 | 2022 | 1002 | 0.190 |
Why?
|
| Immunity | 1 | 2022 | 189 | 0.190 |
Why?
|
| Proteomics | 3 | 2018 | 501 | 0.190 |
Why?
|
| Pyridines | 2 | 2020 | 229 | 0.190 |
Why?
|
| Drug Synergism | 2 | 2019 | 227 | 0.180 |
Why?
|
| Membrane Fluidity | 1 | 2020 | 18 | 0.180 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2017 | 136 | 0.180 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2020 | 30 | 0.180 |
Why?
|
| Oncogenes | 1 | 2021 | 167 | 0.180 |
Why?
|
| Gene Expression | 3 | 2016 | 1560 | 0.180 |
Why?
|
| Ubiquitin-Specific Proteases | 2 | 2018 | 20 | 0.180 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 88 | 0.170 |
Why?
|
| Phospholipids | 1 | 2020 | 105 | 0.170 |
Why?
|
| Circadian Clocks | 1 | 2020 | 59 | 0.170 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 660 | 0.170 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 181 | 0.170 |
Why?
|
| Glucose | 2 | 2015 | 879 | 0.170 |
Why?
|
| Cysteine Endopeptidases | 3 | 2009 | 114 | 0.170 |
Why?
|
| HEK293 Cells | 6 | 2020 | 744 | 0.170 |
Why?
|
| Models, Biological | 5 | 2011 | 1454 | 0.160 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 157 | 0.160 |
Why?
|
| Reproduction | 2 | 2013 | 238 | 0.160 |
Why?
|
| Salivary Glands | 1 | 2019 | 33 | 0.160 |
Why?
|
| Endometriosis | 1 | 2022 | 177 | 0.160 |
Why?
|
| Peptide Hydrolases | 1 | 2000 | 141 | 0.160 |
Why?
|
| DNA | 2 | 2016 | 1595 | 0.160 |
Why?
|
| Enzyme Inhibitors | 2 | 2021 | 577 | 0.160 |
Why?
|
| Lipid Metabolism | 1 | 2022 | 356 | 0.160 |
Why?
|
| Myocardium | 1 | 2024 | 996 | 0.160 |
Why?
|
| RANK Ligand | 1 | 2019 | 52 | 0.160 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2019 | 55 | 0.160 |
Why?
|
| Multiple Myeloma | 1 | 2021 | 169 | 0.160 |
Why?
|
| RNAi Therapeutics | 1 | 2018 | 16 | 0.150 |
Why?
|
| Neoplastic Stem Cells | 2 | 2020 | 295 | 0.150 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2018 | 12 | 0.150 |
Why?
|
| Liver | 2 | 2022 | 1735 | 0.140 |
Why?
|
| Small Molecule Libraries | 2 | 2017 | 126 | 0.140 |
Why?
|
| Benzimidazoles | 2 | 2016 | 132 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 555 | 0.140 |
Why?
|
| Wound Healing | 1 | 2021 | 436 | 0.140 |
Why?
|
| Infertility | 1 | 2018 | 76 | 0.140 |
Why?
|
| Drug Resistance, Multiple | 1 | 2017 | 48 | 0.140 |
Why?
|
| Mice, SCID | 5 | 2018 | 568 | 0.140 |
Why?
|
| Decidua | 1 | 2018 | 140 | 0.140 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 154 | 0.130 |
Why?
|
| Cytokines | 1 | 2022 | 1289 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2011 | 357 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 464 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 4401 | 0.130 |
Why?
|
| Lysosomes | 1 | 2018 | 236 | 0.130 |
Why?
|
| Hydrazones | 1 | 2016 | 19 | 0.130 |
Why?
|
| Transcriptome | 2 | 2019 | 950 | 0.130 |
Why?
|
| E2F1 Transcription Factor | 1 | 2016 | 47 | 0.120 |
Why?
|
| Adenosine Triphosphate | 2 | 2007 | 282 | 0.120 |
Why?
|
| beta Catenin | 1 | 2017 | 204 | 0.120 |
Why?
|
| Mice, Nude | 4 | 2020 | 707 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 395 | 0.120 |
Why?
|
| Prodrugs | 1 | 2015 | 59 | 0.120 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2015 | 7 | 0.120 |
Why?
|
| Twist-Related Protein 1 | 1 | 2015 | 35 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 279 | 0.120 |
Why?
|
| Multiprotein Complexes | 3 | 2013 | 206 | 0.120 |
Why?
|
| Luciferases | 1 | 2015 | 132 | 0.120 |
Why?
|
| RNA Splicing | 2 | 2007 | 227 | 0.120 |
Why?
|
| Receptors, Progesterone | 5 | 2009 | 878 | 0.120 |
Why?
|
| Acetyltransferases | 2 | 2006 | 90 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 307 | 0.120 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 283 | 0.120 |
Why?
|
| Protein Stability | 5 | 2014 | 162 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2020 | 82 | 0.110 |
Why?
|
| Oncogene Proteins | 2 | 2006 | 136 | 0.110 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2014 | 44 | 0.110 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2014 | 42 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 418 | 0.110 |
Why?
|
| RNA, Messenger | 6 | 2023 | 2815 | 0.110 |
Why?
|
| NAD | 1 | 2014 | 46 | 0.110 |
Why?
|
| Binding Sites | 5 | 2018 | 1295 | 0.110 |
Why?
|
| Nucleosomes | 1 | 2013 | 39 | 0.110 |
Why?
|
| Leupeptins | 5 | 2011 | 26 | 0.110 |
Why?
|
| Response Elements | 1 | 2013 | 97 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 1010 | 0.100 |
Why?
|
| Cell Line | 5 | 2024 | 2748 | 0.100 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2013 | 18 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 691 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2012 | 9 | 0.100 |
Why?
|
| Receptor, ErbB-2 | 1 | 2016 | 514 | 0.100 |
Why?
|
| Progesterone | 2 | 2005 | 624 | 0.100 |
Why?
|
| Gossypol | 1 | 2011 | 3 | 0.100 |
Why?
|
| Cullin Proteins | 1 | 2011 | 14 | 0.090 |
Why?
|
| Multienzyme Complexes | 2 | 2003 | 88 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 573 | 0.090 |
Why?
|
| Isoenzymes | 2 | 2009 | 229 | 0.090 |
Why?
|
| Fibrosis | 2 | 2024 | 430 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 163 | 0.090 |
Why?
|
| Disease Progression | 1 | 2016 | 2044 | 0.090 |
Why?
|
| Transfection | 4 | 2017 | 1062 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2010 | 117 | 0.090 |
Why?
|
| Histones | 2 | 2021 | 526 | 0.080 |
Why?
|
| Mitochondria | 1 | 2015 | 680 | 0.080 |
Why?
|
| Ligases | 2 | 2000 | 46 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2020 | 1890 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 3 | 2018 | 1059 | 0.080 |
Why?
|
| Oxidation-Reduction | 2 | 2024 | 440 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 3 | 2018 | 612 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2020 | 2392 | 0.080 |
Why?
|
| Hormones | 1 | 2010 | 186 | 0.080 |
Why?
|
| Selection, Genetic | 1 | 2009 | 154 | 0.080 |
Why?
|
| Cell Cycle | 3 | 2020 | 608 | 0.080 |
Why?
|
| Steroids | 1 | 2010 | 202 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 335 | 0.080 |
Why?
|
| Epithelial Cells | 2 | 2023 | 909 | 0.080 |
Why?
|
| RNA Interference | 3 | 2018 | 498 | 0.070 |
Why?
|
| Endometrial Neoplasms | 1 | 2009 | 97 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 1284 | 0.070 |
Why?
|
| Translocation, Genetic | 2 | 2021 | 357 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2008 | 150 | 0.070 |
Why?
|
| NF-kappa B | 2 | 2022 | 455 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 2045 | 0.070 |
Why?
|
| Down-Regulation | 3 | 2011 | 698 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2003 | 40 | 0.070 |
Why?
|
| Tumor Burden | 2 | 2018 | 230 | 0.070 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2006 | 31 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 1599 | 0.060 |
Why?
|
| Ubiquitination | 3 | 2013 | 169 | 0.060 |
Why?
|
| Apoptosis | 2 | 2024 | 1782 | 0.060 |
Why?
|
| RNA Polymerase II | 1 | 2005 | 100 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2011 | 836 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2008 | 2698 | 0.060 |
Why?
|
| Syndrome | 1 | 2007 | 1119 | 0.060 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 36 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 1544 | 0.060 |
Why?
|
| Male | 8 | 2023 | 61033 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2015 | 311 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2008 | 621 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 3873 | 0.050 |
Why?
|
| Mammals | 2 | 2022 | 256 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2006 | 862 | 0.050 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2003 | 23 | 0.050 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2003 | 38 | 0.050 |
Why?
|
| Mutation | 5 | 2018 | 5816 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 575 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2007 | 674 | 0.050 |
Why?
|
| Piperidines | 1 | 2024 | 204 | 0.050 |
Why?
|
| Molecular Structure | 2 | 2015 | 288 | 0.050 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2017 | 106 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2002 | 86 | 0.050 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 663 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2024 | 306 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 78 | 0.050 |
Why?
|
| RNA, Untranslated | 1 | 2002 | 112 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2024 | 369 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2011 | 1103 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2002 | 427 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2021 | 57 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 38 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2020 | 56 | 0.040 |
Why?
|
| Bortezomib | 1 | 2021 | 73 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 766 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2021 | 69 | 0.040 |
Why?
|
| Estradiol | 2 | 2000 | 535 | 0.040 |
Why?
|
| cdc25 Phosphatases | 1 | 2020 | 21 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2021 | 100 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 237 | 0.040 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 1 | 2020 | 16 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 198 | 0.040 |
Why?
|
| Multigene Family | 1 | 2021 | 297 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 171 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2021 | 209 | 0.040 |
Why?
|
| Ubiquitins | 1 | 1999 | 42 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2021 | 265 | 0.040 |
Why?
|
| Lipids | 1 | 2022 | 513 | 0.040 |
Why?
|
| Pregnancy | 2 | 2023 | 7179 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2018 | 28 | 0.040 |
Why?
|
| Angelman Syndrome | 1 | 1999 | 67 | 0.040 |
Why?
|
| Cycloheximide | 1 | 2018 | 43 | 0.040 |
Why?
|
| Epithelium | 1 | 2019 | 362 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2020 | 346 | 0.040 |
Why?
|
| GATA2 Transcription Factor | 1 | 2018 | 39 | 0.040 |
Why?
|
| Rats | 1 | 2024 | 3676 | 0.040 |
Why?
|
| Proteins | 1 | 2003 | 1036 | 0.040 |
Why?
|
| Luminescence | 1 | 2017 | 15 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1491 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1421 | 0.030 |
Why?
|
| Plasmids | 1 | 2018 | 510 | 0.030 |
Why?
|
| Macrophages | 1 | 2020 | 614 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3150 | 0.030 |
Why?
|
| Doxycycline | 1 | 2017 | 117 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 86 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 1388 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2015 | 152 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 92 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 120 | 0.030 |
Why?
|
| Kinetics | 2 | 2011 | 1321 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 209 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2014 | 33 | 0.030 |
Why?
|
| DNA Replication | 1 | 2016 | 352 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 197 | 0.030 |
Why?
|
| Digoxin | 1 | 2014 | 43 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 2013 | 48 | 0.030 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2013 | 18 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2015 | 224 | 0.030 |
Why?
|
| Tetrazolium Salts | 1 | 2013 | 15 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 60 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 270 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2015 | 256 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 1428 | 0.030 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2013 | 52 | 0.030 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2013 | 17 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 90 | 0.030 |
Why?
|
| Computational Biology | 1 | 2018 | 808 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 313 | 0.030 |
Why?
|
| Lentivirus | 1 | 2013 | 82 | 0.030 |
Why?
|
| Thiazoles | 1 | 2013 | 98 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2013 | 114 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 483 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 66 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 3038 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 354 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 76 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2011 | 38 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 830 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 371 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 503 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1010 | 0.020 |
Why?
|
| Animal Structures | 1 | 2010 | 7 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 310 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 127 | 0.020 |
Why?
|
| Substrate Specificity | 2 | 2002 | 290 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6467 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 436 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2010 | 290 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 368 | 0.020 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2009 | 13 | 0.020 |
Why?
|
| RNA Stability | 1 | 2010 | 84 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2013 | 778 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2013 | 939 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 134 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 97 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2009 | 98 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2013 | 875 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 1015 | 0.020 |
Why?
|
| Testis | 1 | 2010 | 409 | 0.020 |
Why?
|
| Trefoil Factor-1 | 1 | 2007 | 7 | 0.020 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2007 | 20 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 144 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2007 | 106 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2008 | 164 | 0.020 |
Why?
|
| F-Box Proteins | 1 | 2007 | 34 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 757 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 217 | 0.020 |
Why?
|
| Cell Enlargement | 1 | 2006 | 9 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 656 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2011 | 1022 | 0.020 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2005 | 79 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2005 | 18 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2005 | 37 | 0.010 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2005 | 54 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 2007 | 190 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 1010 | 0.010 |
Why?
|
| Time Factors | 2 | 2005 | 6279 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 641 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 2003 | 64 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 19545 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 1357 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 26608 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 29367 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 776 | 0.010 |
Why?
|
| RNA, Long Noncoding | 1 | 2002 | 210 | 0.010 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1999 | 84 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 1999 | 72 | 0.010 |
Why?
|
| Arabidopsis | 1 | 1999 | 70 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 657 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 890 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1999 | 970 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 3089 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1999 | 985 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 4251 | 0.000 |
Why?
|